Endpoint definition
↥| Name | ASTHMA_PNEUMONIA |
|---|---|
| Long name | Asthma-related pneumonia |
| Conditions required | J10_ASTHMA |
| Include | VIRALPNEUMOKNOWN, VIRALPNEUMONAS, MYCOBLUNGATYPICA, J10_PNEUMONAS, PNEUMOBACTKNOWN |
| First defined in version | DF2 |
Asthma-related pneumonia
pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5532 | 3037 | 2495 |
| Unadjusted prevalence (%) | 2.55 | 2.47 | 2.65 |
| Mean age at first event (years) | 52.53 | 51.59 | 53.67 |
| Case fatality at 5-years (%) | 10.81 | 8.56 | 13.55 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 15.00 | 14.07 | 15.78 |
Survival analyses between endpoints
↥Plot
before Asthma-related pneumonia
after Asthma-related pneumonia
Loading survival analyses plot…
Table
Loading survival analyses table…